• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance.简短通讯:定义用于HIV发病率监测的近期感染检测的最优性
AIDS Res Hum Retroviruses. 2014 Jan;30(1):45-9. doi: 10.1089/aid.2013.0113. Epub 2013 Oct 26.
2
Principles and uses of HIV incidence estimation from recent infection testing--a review.基于近期感染检测的HIV发病率估算的原理与应用——综述
Euro Surveill. 2008 Sep 4;13(36):18969.
3
Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review.用于检测HIV近期感染及估计人群发病率的血清学检测方法的准确性:一项系统评价
Lancet Infect Dis. 2009 Dec;9(12):747-59. doi: 10.1016/S1473-3099(09)70300-7.
4
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.通过用于HIV-1/2确认的免疫印迹法评估近期HIV-1感染情况。
PLoS Med. 2007 Dec;4(12):e343. doi: 10.1371/journal.pmed.0040343.
5
Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation.作为一种资源,血清转化献血者可用于描述和优化最近的感染检测算法,以估计发病率。
PLoS One. 2011;6(6):e20027. doi: 10.1371/journal.pone.0020027. Epub 2011 Jun 9.
6
HIV incidence determination in the United States: a multiassay approach.美国 HIV 发病率的测定:多分析法。
J Infect Dis. 2013 Jan 15;207(2):232-9. doi: 10.1093/infdis/jis659. Epub 2012 Nov 5.
7
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.利用新的限性抗原亲和力测定法检测近期 HIV-1 感染:用于 HIV-1 发病率估计和亲和力成熟研究的潜力。
PLoS One. 2012;7(3):e33328. doi: 10.1371/journal.pone.0033328. Epub 2012 Mar 27.
8
Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study.采用多方面方法分析美国女性队列研究中的 HIV 发病率:HIV 预防试验网络 064 研究。
J Infect Dis. 2013 Jan 15;207(2):223-31. doi: 10.1093/infdis/jis658. Epub 2012 Nov 5.
9
Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.在资源有限的国家使用近期感染检测方法监测HIV-1发病率
AIDS. 2005 May;19 Suppl 2:S25-30. doi: 10.1097/01.aids.0000172874.90133.7a.
10
Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.评估多种检测算法在估计HIV-1 C亚型发病率时的近期错误分类率。
AIDS Res Hum Retroviruses. 2014 Jan;30(1):29-36. doi: 10.1089/aid.2013.0055. Epub 2013 Sep 6.

引用本文的文献

1
The impact of non-disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms.未披露 HIV 状况和抗逆转录病毒疗法对 HIV 近期检测和发病算法的影响。
Vox Sang. 2024 Jun;119(6):581-589. doi: 10.1111/vox.13627. Epub 2024 Apr 15.
2
Subnational HIV incidence trends in Malawi: large, heterogeneous declines across space.马拉维次国家级别的艾滋病毒感染率趋势:各地出现大幅且不均衡的下降。
medRxiv. 2023 Feb 4:2023.02.02.23285334. doi: 10.1101/2023.02.02.23285334.
3
Recent HIV Infection: Diagnosis and Public Health Implications.近期HIV感染:诊断及对公共卫生的影响
Diagnostics (Basel). 2022 Nov 1;12(11):2657. doi: 10.3390/diagnostics12112657.
4
Recent HIV infection among pregnant women in the 2017 antenatal sentinel cross-sectional survey, South Africa: Assay-based incidence measurement.2017 年南非产前哨点横断面调查中孕妇的近期 HIV 感染:基于检测的发病率测量。
PLoS One. 2021 Apr 14;16(4):e0249953. doi: 10.1371/journal.pone.0249953. eCollection 2021.
5
Antibody avidity-based approach to estimate population-level incidence of hepatitis C.基于抗体亲和力的方法估计丙型肝炎的人群发病水平。
J Hepatol. 2020 Aug;73(2):294-302. doi: 10.1016/j.jhep.2020.03.028. Epub 2020 Mar 30.
6
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.用于 HIV 发病率监测的 Maxim 和 Sedia 限抗原亲和力检测的性能比较。
PLoS One. 2019 Jul 26;14(7):e0220345. doi: 10.1371/journal.pone.0220345. eCollection 2019.
7
Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.乌干达拉凯地区A/D型艾滋病流行中用于估计HIV发病率水平及趋势的有限抗原亲和力检测法的验证
AIDS Res Hum Retroviruses. 2019 Apr;35(4):364-367. doi: 10.1089/AID.2018.0207. Epub 2019 Jan 29.
8
Computational analysis of antibody dynamics identifies recent HIV-1 infection.计算分析抗体动力学可识别近期 HIV-1 感染。
JCI Insight. 2017 Dec 21;2(24):94355. doi: 10.1172/jci.insight.94355.
9
Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.高动态范围诊断免疫分析平台的感染分期及发病率监测应用
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):547-555. doi: 10.1097/QAI.0000000000001537.
10
Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.希腊注射吸毒者中限制性抗原亲和力酶免疫分析(LAg)的评估。
Epidemiol Infect. 2017 Jan;145(2):401-412. doi: 10.1017/S0950268816002417. Epub 2016 Oct 26.

本文引用的文献

1
Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.自然和 ARV 诱导的病毒抑制及病毒突破对 HIV-1 亚型 B 感染患者抗 HIV 抗体比例和亲和力的影响。
PLoS One. 2013;8(2):e55525. doi: 10.1371/journal.pone.0055525. Epub 2013 Feb 20.
2
Decreased specificity of an assay for recent infection in HIV-1-infected patients on highly active antiretroviral treatment: implications for incidence estimates.高效抗逆转录病毒治疗的HIV-1感染患者近期感染检测方法的特异性降低:对发病率估计的影响
Clin Vaccine Immunol. 2012 Aug;19(8):1248-53. doi: 10.1128/CVI.00120-12. Epub 2012 Jun 20.
3
A new general biomarker-based incidence estimator.一种新的基于通用生物标志物的发病估计方法。
Epidemiology. 2012 Sep;23(5):721-8. doi: 10.1097/EDE.0b013e3182576c07.
4
Workshop summary: Novel biomarkers for HIV incidence assay development.研讨会总结:用于开发HIV发病率检测的新型生物标志物
AIDS Res Hum Retroviruses. 2012 Jun;28(6):532-9. doi: 10.1089/aid.2011.0332. Epub 2012 Feb 24.
5
Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.使用BED捕获免疫测定法与近期HIV感染错误识别相关的因素。
AIDS Res Hum Retroviruses. 2012 Aug;28(8):816-22. doi: 10.1089/aid.2011.0258. Epub 2011 Dec 1.
6
More and better information to tackle HIV epidemics: towards improved HIV incidence assays.更多更好的信息来应对艾滋病疫情:朝着改进 HIV 发病率检测方法的方向努力。
PLoS Med. 2011 Jun;8(6):e1001045. doi: 10.1371/journal.pmed.1001045. Epub 2011 Jun 14.
7
Designing a genome-based HIV incidence assay with high sensitivity and specificity.设计一种具有高灵敏度和特异性的基于基因组的 HIV 发病率检测方法。
AIDS. 2011 Oct 23;25(16):F13-9. doi: 10.1097/QAD.0b013e328349f089.
8
Estimating the HIV incidence rate: recent and future developments.估算 HIV 发病率:近期和未来的发展。
Curr Opin HIV AIDS. 2011 Mar;6(2):102-7. doi: 10.1097/COH.0b013e328343bfdb.
9
Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.超越失谐:HIV发病率估算检测方法开发与应用十年进展及新挑战
AIDS. 2010 Nov 27;24(18):2763-71. doi: 10.1097/QAD.0b013e32833f1142.
10
Using tests for recent infection to estimate incidence: problems and prospects for HIV.利用近期感染检测来估计发病率:HIV 的问题与展望。
Euro Surveill. 2010 Jun 17;15(24):19589.

简短通讯:定义用于HIV发病率监测的近期感染检测的最优性

Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance.

作者信息

Kassanjee Reshma, McWalter Thomas A, Welte Alex

机构信息

1 The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch , Stellenbosch, South Africa .

出版信息

AIDS Res Hum Retroviruses. 2014 Jan;30(1):45-9. doi: 10.1089/aid.2013.0113. Epub 2013 Oct 26.

DOI:10.1089/aid.2013.0113
PMID:24090052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3887426/
Abstract

The estimation of HIV incidence from cross-sectional surveys using tests for recent infection has attracted much interest. It is increasingly recognized that the lack of high performance recent infection tests is hindering the implementation of this surveillance approach. With growing funding opportunities, test developers are currently trying to fill this gap. However, there is a lack of consensus and clear guidance for developers on the evaluation and optimization of candidate tests. A fundamental shift from conventional thinking about test performance is needed: away from metrics relevant in typical public health settings where the detection of a condition in individuals is of primary interest (sensitivity, specificity, and predictive values) and toward metrics that are appropriate when estimating a population-level parameter such as incidence (accuracy and precision). The inappropriate use of individual-level diagnostics performance measures could lead to spurious assessments and suboptimal designs of tests for incidence estimation. In some contexts, such as population-level application to HIV incidence, bias of estimates is essentially negligible, and all that remains is the maximization of precision. The maximization of the precision of incidence estimates provides a completely general criterion for test developers to assess and optimize test designs. Summarizing the test dynamics into the properties relevant for incidence estimation, high precision estimates are obtained when (1) the mean duration of recent infection is large, and (2) the false-recent rate is small. The optimal trade-off between these two test properties will produce the highest precision, and therefore the most epidemiologically useful incidence estimates.

摘要

利用近期感染检测方法通过横断面调查来估计艾滋病毒发病率已引起广泛关注。人们越来越认识到,缺乏高性能的近期感染检测方法正阻碍着这种监测方法的实施。随着资金机会的增加,检测方法开发者目前正试图填补这一空白。然而,在候选检测方法的评估和优化方面,开发者缺乏共识和明确的指导。需要从对检测性能的传统思维方式上进行根本性转变:从典型公共卫生环境中与个体疾病检测相关的指标(敏感性、特异性和预测值)转向在估计发病率等人群水平参数时适用的指标(准确性和精密度)。不恰当地使用个体水平的诊断性能指标可能会导致虚假评估以及发病率估计检测方法的次优设计。在某些情况下,比如在艾滋病毒发病率的人群水平应用中,估计偏差基本上可以忽略不计,剩下的就是精密度的最大化。发病率估计精密度的最大化提供了一个完全通用的标准,供检测方法开发者评估和优化检测设计。将检测动态归纳为与发病率估计相关的特性,当(1)近期感染的平均持续时间较长,以及(2)假近期感染率较低时,可获得高精度估计值。这两种检测特性之间的最佳权衡将产生最高的精密度,从而得到在流行病学上最有用的发病率估计值。